FDA Adverse Event Malfunction Summary report: N

NOVA STATSTRIP GLUCOSE HOSPITAL METER SYSTEM

MDR report key: 11507402 · Received March 17, 2021

Report

Report Number
1219029-2021-00006
Event Type
Malfunction
Date Received
March 17, 2021
Date of Event
February 12, 2021
Report Date
May 13, 2021
Manufacturer
NOVA BIOMEDICAL CORP
Product Code
CGA
UDI-DI
00385480533980
PMA / PMN Number
K063821
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TH
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

THE CUSTOMER REPORTED AN INCORRECT ACCOUNT NUMBER SHOWN WHEN SCANNED BY THE STATSTRIP 1.75 METER SN (B)(6). THE METER SCANNED A PATIENT IDENTIFICATION NUMBER HOWEVER; RECEIVED INCORRECT OUTPUT THAT DID NOT MATCH. THE CUSTOMER STATES THEY ARE UNAWARE OF ANY PATIENT HARM FROM THE BARCODE MISREAD AND WILL NOT BE RETURNING THE METER AS IT IS CURRENTLY IN USE AT THE FACILITY. TO DATE, THE PRODUCT HAS NOT BEEN RECEIVED FOR EVALUATION. WITHOUT THE RETURNED PRODUCT A DETAILED INVESTIGATION ON THE FAILED PRODUCT COULD NOT BE PERFORMED, AND THE REPORTED CONDITION COULD NOT BE CONFIRMED. THE CAUSE(S) OF THE DIFFICULTY REPORTED BY THE CUSTOMER COULD NOT BE DETERMINED. A DEVICE HISTORY RECORD (DHR) REVIEW FOR THE STATSTRIP METER SN (B)(6) WAS PERFORMED BY A QUALITY CONTROL ENGINEER. THE REVIEW INCLUDED AN ASSESSMENT OF THE PRODUCTION, TESTING, AND RELEASE OF THE PRODUCTS. NO ABNORMALITIES OR CONCERNS WERE OBSERVED; THE DHR INDICATED THE RELEASED PRODUCT MET ALL SPECIFICATIONS. COMPLAINT WILL BE CLOSED AS 'NO COMPLAINT SAMPLE RETURNED TO NOVA FOR EVALUATION'. IF THE COMPLAINT SAMPLE BECOMES AVAILABLE, THIS COMPLAINT WILL BE REOPENED, AND THE RESPECTIVE EVALUATION PERFORMED. A CAPA (CORRECTIVE AND PREVENTATIVE ACTION) IS NOT REQUIRED AS A RESULT OF THIS INVESTIGATION BECAUSE THE COMPLAINT WAS NOT CONFIRMED. NOVA WILL CONTINUE TO MONITOR FOR RECURRENCE, NO FURTHER ACTION IS REQUIRED AT THIS TIME.

Additional Manufacturer Narrative · 0

ADDITIONAL AND CORRECTED INFORMATION: B4, D9, G6, H1, H2, H3, H10. AN INVESTIGATION HAS BEEN INITIATED AND IS CURRENTLY PENDING. FURTHER DETAILS WILL BE PROVIDED IN AN ADDITIONAL SUPPLEMENTAL REPORT WHEN THEY BECOME AVAILABLE.

Additional Manufacturer Narrative · 1

THERE WAS NO REPORTED PATIENT HARM OR INTERVENTION. THERE IS CURRENTLY A PENDING INVESTIGATION. A REQUEST HAS BEEN SENT TO THE CUSTOMER OBTAIN METERS AND BARCODE OR SAMPLE OF A TEST BARCODE FOR VERIFICATION OF 1-D VERSUS 2-D BARCODES. ADDITIONAL INFORMATION AND FURTHER DETAILS WILL BE PROVIDED IN A SUPPLEMENTAL REPORT.

Description of Event or Problem · 1

A CUSTOMER REPORTED THAT GLUC CONN METERS (1.75) MIS-SCANNING 1D BAR SHOWING INCORRECT PATIENT ID'S. THE ACCOUNT HAS 1 & 2 D BAR CODES ON PATIENTS WRISTS. THERE HAS BEEN NO REPORT OF PATIENT HARM OR ADVERSE EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
403726 NOVA STATSTRIP GLUCOSE HOSPITAL METER SYSTEM BLOOD GLUCOSE METER CGA NOVA BIOMEDICAL CORP 53398 00385480533980

Patients

Seq Age Sex Outcome Treatment
1